Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05371613 |
| Consolidated Lead Sponsor | Denali Therapeutics |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 65 participants (ACTUAL) |
| Registered Start Date | 2022-07-21 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| UCSF Benioff Children's Hospital Oakland | Oakland, CA | Open Hospital Dossier -> |
| Hackensack University Medical Center | Hackensack, NJ | Open Hospital Dossier -> |
| Cincinnati Children's Hospital Medical Center | Cincinnati, OH | Open Hospital Dossier -> |
| Children's Hospital of Philadelphia | Philadelphia, PA | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.